In March 2025, the company introduced new programs for the direct-to-buyer supplying of its Wegovy weight loss drug. The company set up a whole new pharmacy, referred to as NovoCare, which might demand consumers $499 each month for use of the drug, fewer than half the cost of the drug by means of other pharmaceutical distribution networks.[53]The m